Overcoming the limitations of cytokines to improve cancer therapy

Area of Science:

• Immunology
• Biotechnology
• Oncology

Background:

• Cytokines are crucial soluble proteins mediating immune cell communication.
• They play a vital role in orchestrating responses against pathogens and cancer.
• Cytokine-based drugs are explored for cancer immunotherapy by modulating pro-inflammatory or immunosuppressive cytokines.

Purpose of the Study:

• To review current biotechnological strategies for optimizing cytokine-based cancer immunotherapy.
• To highlight methods for enhancing cytokine efficacy and minimizing systemic toxicity.
• To provide an overview of pre-clinical and clinical applications of these strategies.

Main Methods:

• Review of literature on cytokine engineering and delivery systems.
• Analysis of sequence mutagenesis, fusion proteins, and gene therapy applications.
• Examination of strategies to improve half-life, tumor targeting, and therapeutic window.

Main Results:

• Biotechnological approaches can enhance cytokine circulation half-life.
• Strategies exist to specifically target cytokine bioactivity to the tumor microenvironment.
• Optimizing cytokine delivery improves the therapeutic window for cancer treatment.

Conclusions:

• Advanced biotechnological strategies are essential for effective cytokine-based cancer immunotherapy.
• These methods offer promise in overcoming challenges of systemic toxicity and improving antitumor responses.
• Continued research in pre-clinical and clinical settings is vital to fully harness cytokine potential in oncology.